Date published: 2025-10-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

RPAP3 Inhibitors

RPAP3 inhibitors represent a chemical class designed to target the RPAP3 (RNA Polymerase II-associated Protein 3) component of the R2TP complex, which plays a crucial role in the assembly and stabilization of multi-protein complexes involved in fundamental cellular processes. RPAP3 is essential for the biogenesis of various protein complexes, such as RNA polymerase II, which governs transcriptional regulation in cells. Additionally, RPAP3 is involved in chaperoning proteins for proper folding and maintaining the integrity of molecular machines like the PIKK (Phosphatidylinositol 3-kinase-related kinase) family, influencing DNA damage response pathways, cellular growth, and metabolism. The inhibitors of RPAP3 target this scaffolding function, preventing the appropriate assembly or activity of the protein complexes dependent on RPAP3 for their stability and operation. As a result, these inhibitors are useful tools in studying how RPAP3 and its associated protein interactions impact cell homeostasis and proteostasis.

Structurally, RPAP3 inhibitors typically exhibit specific interactions with the RPAP3 protein domain, blocking its ability to bind with client proteins or cofactors required for the proper function of the R2TP complex. By interfering with these protein-protein interactions, RPAP3 inhibitors can disrupt critical cellular pathways without directly inhibiting enzymatic activity. This makes them valuable in dissecting the mechanisms by which molecular chaperone complexes facilitate the assembly of large, dynamic multi-protein structures. The study of RPAP3 inhibitors also offers insight into how the inhibition of protein-protein interactions can affect diverse cellular functions such as transcriptional control, protein synthesis, and stress response pathways. Through these inhibitors, researchers can explore the fine balance of protein stability and interaction networks critical for maintaining cell structure and function.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

DRB

53-85-0sc-200581
sc-200581A
sc-200581B
sc-200581C
10 mg
50 mg
100 mg
250 mg
$42.00
$185.00
$310.00
$650.00
6
(1)

Inhibits the activity of positive transcription elongation factor b (P-TEFb). Can influence RNA Pol II-mediated transcription.

α-Amanitin

23109-05-9sc-202440
sc-202440A
1 mg
5 mg
$260.00
$1029.00
26
(2)

Directly inhibits RNA polymerase II. Could hinder processes where RPAP3 plays a role.

Flavopiridol

146426-40-6sc-202157
sc-202157A
5 mg
25 mg
$78.00
$254.00
41
(3)

Cyclin-dependent kinase (CDK) inhibitor. CDKs regulate RNA Pol II phosphorylation.

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$73.00
$238.00
$717.00
$2522.00
$21420.00
53
(3)

Intercalates DNA, preventing RNA synthesis by RNA polymerases.

Triptolide

38748-32-2sc-200122
sc-200122A
1 mg
5 mg
$88.00
$200.00
13
(1)

Known to repress transcription by RNA polymerase II.

Roscovitine

186692-46-6sc-24002
sc-24002A
1 mg
5 mg
$92.00
$260.00
42
(2)

CDK inhibitor, potentially affecting RNA Pol II phosphorylation.

H-7, Dihydrochloride

108930-17-2sc-24009
sc-24009A
10 mg
50 mg
$80.00
$319.00
(1)

Inhibits multiple kinases, which could indirectly affect RPAP3-associated processes.

Cordycepin

73-03-0sc-203902
10 mg
$99.00
5
(1)

Analog of adenosine, can lead to premature termination of RNA synthesis.

Isoginkgetin

548-19-6sc-507430
5 mg
$225.00
(0)

Inhibits splicing of pre-mRNAs, could interfere in processes downstream of RPAP3.

Pladienolide B

445493-23-2sc-391691
sc-391691B
sc-391691A
sc-391691C
sc-391691D
sc-391691E
0.5 mg
10 mg
20 mg
50 mg
100 mg
5 mg
$290.00
$5572.00
$10815.00
$25000.00
$65000.00
$2781.00
63
(2)

Targets the spliceosome, potentially affecting processes associated with RPAP3.